Delivery Order SPE2DB24D2205-SPE2DB25FEFMN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Corlanor 7.5 mg tablets (60-count units) at a firm fixed price of $1,165.23. This non-set-aside delivery order represents a child contract vehicle under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract utilizes a firm fixed-price structure and is scheduled for ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $10,749.07, with an ultimate completion date of July 25, 2025. This non-set-aside award was competitively procured and represents a single delivery order fulfillment for pharmaceutical products. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,137 delivery order to Amerisourcebergen Drug Corporation for 4562195687 Corlanor 5 MG tablets. Under this firm fixed price contract, Amerisourcebergen will provide 60 tablets of the specified medication to an address in Conshohocken, Pennsylvania, with performance required between September 15-18, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen frequently receives such small dollar,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for CORLANOR 5 MG tablets (60-count packages) with a ceiling value of $38,930.45. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by July 28, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,989.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of July 28, 2025. This is a firm fixed price, non-set-aside contract classified as a child award, indicating it derives from a larger contract vehicle. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,848.11 firm fixed-price delivery order is for the supply of 4,567,874,703 units of the medication Corlanor 5 mg tablets. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,809.83, is for the supply of 4,568,108,411 units of the medication Corlanor 5 mg tablet. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $5,219.40, is for the delivery of Corlanor 5 MG Tablet 60s, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $5,465.20 firm fixed price delivery order is for the supply of CORLANOR 5 MG TABLET 60S, a medication, with a performance period extending through June 13, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFMNDelivery Order
The Defense Logistics Agency awarded a $9,479.97 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 that enables the company to distribute a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. The DLA Troop Support Medical contract represents the company's capability to meet federal procurement requirements across multiple therapeutic domains, with delivery orders ranging from minimal to substantial values. The award supports the Defense Health Agency and other government healthcare systems through flexible procurement mechanisms, with the DLA planning future Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards across different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 7/28/25 |